Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
CERo Therapeutics Holdings, Inc. (CERO) had Weighted-Average Shares Outstanding (Diluted) of 4.23M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-48.45M |
|
-- |
|
-- |
|
$4.43M |
|
$-4.43M |
|
$-0.11M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.43M |
|
$-4.15M |
|
4.23M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.23M |
$80.03 |
|
$80.03 |
|
| Balance Sheet Financials | |
$2.73M |
|
$0.25M |
|
$0.91M |
|
$3.64M |
|
$9.09M |
|
-- |
|
-- |
|
$9.09M |
|
$-12.71M |
|
$-5.45M |
|
$-5.45M |
|
21102.67B |
|
| Cash Flow Statement Financials | |
$-16.08M |
|
$0.50M |
|
$13.92M |
|
$3.33M |
|
$1.66M |
|
$-1.66M |
|
$1.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.73% |
|
83.37% |
|
-124.70% |
|
83.37% |
|
$0.00 |
|
$-3.68 |
|
$-3.80 |
|